BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2185367)

  • 1. Involvement of the bcl-2 gene in Hodgkin's disease.
    Stetler-Stevenson M; Crush-Stanton S; Cossman J
    J Natl Cancer Inst; 1990 May; 82(10):855-8. PubMed ID: 2185367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes.
    Corbally N; Grogan L; Keane MM; Devaney DM; Dervan PA; Carney DN
    Am J Clin Pathol; 1994 Jun; 101(6):756-60. PubMed ID: 8209865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal abnormalities in patients with Hodgkin's disease: evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells.
    Poppema S; Kaleta J; Hepperle B
    J Natl Cancer Inst; 1992 Dec; 84(23):1789-93. PubMed ID: 1433367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.
    Athan E; Chadburn A; Knowles DM
    Am J Pathol; 1992 Jul; 141(1):193-201. PubMed ID: 1632463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus.
    Bhagat SK; Medeiros LJ; Weiss LM; Wang J; Raffeld M; Stetler-Stevenson M
    Am J Clin Pathol; 1993 May; 99(5):604-8. PubMed ID: 8388163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease.
    Louie DC; Kant JA; Brooks JJ; Reed JC
    Am J Pathol; 1991 Dec; 139(6):1231-7. PubMed ID: 1750500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of mbr bcl-2/JH fusion genes in Hodgkin's disease.
    Kneba M; Eick S; Herbst H; Pott C; Bolz I; Dallenbach F; Hiddemann W; Stein H
    J Pathol; 1995 Apr; 175(4):381-9. PubMed ID: 7790991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
    LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
    Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
    Lee JT; Innes DJ; Williams ME
    J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.
    Cleary M; Rosenberg SA
    J Natl Cancer Inst; 1990 May; 82(10):808-9. PubMed ID: 2185366
    [No Abstract]   [Full Text] [Related]  

  • 11. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
    Weiss LM; Warnke RA; Sklar J; Cleary ML
    N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
    Nakamine H; Masih AS; Chan WC; Sanger WG; Armitage JO; Weisenburger DD
    Leuk Lymphoma; 1993 May; 10(1-2):79-88. PubMed ID: 8374527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
    Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
    Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
    [No Abstract]   [Full Text] [Related]  

  • 15. The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease.
    Gupta RK; Lister TA; Bodmer JG
    Leukemia; 1994 Aug; 8(8):1337-41. PubMed ID: 8057670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
    Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
    Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.
    Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Hübner K; Fischer R; Georgii A
    Virchows Arch; 1995; 426(1):37-41. PubMed ID: 7704322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease.
    Lorenzen J; Hansmann ML; Pezzella F; Hesse C; Kneba M; Gatter KC; Fischer R
    Hum Pathol; 1992 Nov; 23(11):1205-9. PubMed ID: 1427749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
    Butler M; Corbally N; Dervan PA; Carney DN
    Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.